Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Psoriatic Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01752634
What this trial is testing

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)Study completedNCT06624228
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 553
Not applicableStudy completedNCT04540809
What this trial is testing

The Effect of Psoriatic Arthritis on the Functions of the Hand

Who this might be right for
Psoriatic Arthropathy HandPsoriatic Arthritis
Inonu University 56
Testing effectiveness (Phase 2)Looking for participantsNCT07801495
What this trial is testing

Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Moderate to Severe Psoriatic Arthritis
Novartis Pharmaceuticals 220
Large-scale testing (Phase 3)Active Not RecruitingNCT04314531
What this trial is testing

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Who this might be right for
Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited 296
Post-approval studies (Phase 4)Study completedNCT03733925
What this trial is testing

Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Spondylitis, AnkylosingArthritis, Psoriatic
Johnson & Johnson Private Limited 100
Testing effectiveness (Phase 2)UnknownNCT06176508
What this trial is testing

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Hansoh BioMedical R&D Company 160
Not applicableStudy completedNCT02414633
What this trial is testing

Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])

Who this might be right for
Psoriatic Arthritis
AbbVie 148
Large-scale testing (Phase 3)Study completedNCT01009086
What this trial is testing

The Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 615
Testing effectiveness (Phase 2)Ended earlyNCT02429895
What this trial is testing

A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

Who this might be right for
Psoriatic Arthritis
AbbVie 168
Testing effectiveness (Phase 2)Study completedNCT02980692
What this trial is testing

Efficacy and Safety Study of SUNPG1623

Who this might be right for
Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited 391
Testing effectiveness (Phase 2)Study completedNCT03926195
What this trial is testing

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis+1 more
Lakefront Biotherapeutics NV 109
Large-scale testing (Phase 3)Study completedNCT02721966
What this trial is testing

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Who this might be right for
Axial Psoratic Arthritis
Novartis Pharmaceuticals 503
Large-scale testing (Phase 3)Study completedNCT02294227
What this trial is testing

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Novartis Pharmaceuticals 341
Large-scale testing (Phase 3)Active Not RecruitingNCT03675308
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

Who this might be right for
Psoriatic Arthritis
AbbVie 964
Large-scale testing (Phase 3)Study completedNCT02349295
What this trial is testing

Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 363
Not applicableUnknownNCT02572700
What this trial is testing

Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis

Who this might be right for
Psoriatic ArthritisPsoriasisHealthy Controls
Frederiksberg University Hospital 400
Large-scale testing (Phase 3)Study completedNCT04209205
What this trial is testing

Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 381
Large-scale testing (Phase 3)Study completedNCT04109976
What this trial is testing

Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 214
Testing effectiveness (Phase 2)WithdrawnNCT04680676
What this trial is testing

Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Boehringer Ingelheim
Next Page